Poster Presentations at AACR 2022 Annual Meeting for OBI-3424 and Globo H Science

Title: OBI-3424, an AKR1C3-activated prodrug, exhibits in vivo synergistic anti-tumor effect in combination with pembrolizumab by induction of immunogenic cell death Poster number: 6111 / Abstract number: 2922 Title: High Globo-H expression associated with poor survival of gastric cancer patients and enriched PD-L1 expression Poster Number: 6138 / Abstract number: 1742

The release as fetched from its publisher. obipharma.com ↗